Combination therapy decreased the cell viability and promoted the non-melanoma-initiating cell apoptosis, inhibited primary sphere formation, decreased the number of ALDH+ cells, and suppressed the melanoma-initiating cells’ self-renewability ability in vitro. The gene discussed is LDHA; the disease is melanoma.